Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial. - Mc Causland FR; Vaduganathan M; Claggett B; Gori M; Jhund PS; McGrath MM; Neuen BL; Packer M; Pfeffer MA; Rouleau JL; Senni M; Swedberg K; et al. (JACC. Heart failure, 2025)